A 12-week, randomized, double-blind, multi-center, vehicle-controlled, parallel group study to assess the efficacy and safety of the diclofenac sodium gel 1% for the relief of signs and symptoms in patients with osteoarthritis of the knee

Trial Profile

A 12-week, randomized, double-blind, multi-center, vehicle-controlled, parallel group study to assess the efficacy and safety of the diclofenac sodium gel 1% for the relief of signs and symptoms in patients with osteoarthritis of the knee

Completed
Phase of Trial: Phase III

Latest Information Update: 17 Dec 2007

At a glance

  • Drugs Diclofenac (Primary)
  • Indications Musculoskeletal pain; Osteoarthritis
  • Focus Therapeutic Use
  • Sponsors Novartis
  • Most Recent Events

    • 17 Dec 2007 Status changed from in progress to completed.
    • 22 May 2007 The expected completion date for this trial is now 1 Jun 2007.
    • 19 Feb 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top